Moderna ($MRNA) steps into Thursday’s analyst day with more pressure than momentum. The stock is down more than 40% this year ...

Shares of Moderna are falling Thursday. The company made two significant announcements regarding its finances and business ...

CHONGQING, CHINA - JULY 29: In this photo illustration, a smartphone displays the logo of Moderna Inc. (NASDAQ: MRNA), a biotechnology company known for its mRNA-based vaccines and therapeutics, in ...

The S&P 500 Healthcare sector (XLV) experienced a slight rise in average short interest during October, moving from 1.91% to 2.00%. Within this sector, Moderna (MRNA) remains the most heavily shorted ...

Boston-based Moderna has been the S&P 500’s most shorted stock since the end of September, according to S3 Partners. Short ...

Shares of Moderna MRNA were up 4% yesterday after the company announced positive preliminary immunogenicity data from an ongoing phase IV study, which evaluated the updated version of its COVID-19 ...

Investors in Moderna Inc (Symbol: MRNA) saw new options begin trading today, for the November 7th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the MRNA options ...

The COVID-19 vaccine maker reported quarterly sales of $1.02 billion, topping the expected $886.54 million. Sales declined 45% to $1.9 billion from a year ago, primarily due to a $847 million, or 47%, ...

Moderna ( (MRNA)) has provided an update. On November 12, 2025, Moderna, Inc. held a Special Meeting of Shareholders where two proposals were approved. The first was a one-time stock option exchange ...